Healthcare
1099 companies in this sector
Insider Buys (30d)
206
$253.50M
Insider Sells (30d)
681
$5.20B
Monthly Insider Volume
Industries
Biotechnology625 companies
Medical - Devices134 companies
Drug Manufacturers - Specialty & Generic66 companies
Medical - Instruments & Supplies54 companies
Medical - Diagnostics & Research53 companies
Medical - Healthcare Information Services50 companies
Medical - Care Facilities43 companies
Drug Manufacturers - General22 companies
Medical - Pharmaceuticals16 companies
Medical - Healthcare Plans13 companies
Medical - Distribution12 companies
Medical - Equipment & Services8 companies
Medical - Specialties3 companies
Top Companies by Market Cap
Recent Insider Trades
| Date | Ticker | Company | Insider | Role | Type | Shares | Avg Price | Value |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | IRIX | IRIDEX Corporation | Dizon Romeo R | officer: Chief Financial Officer | Buy | 1,675 | $1.14 | $1.9K |
| Jun 12, 2026 | WOK | WORK Medical Technology Group Ltd. | HRT FINANCIAL LP | 10 percent owner | Buy | 3,794,711 | $0.10 | $363.5K |
| Jun 12, 2026 | TDOC | Teladoc Health, Inc. | DIVITA CHARLES III | director, officer: CHIEF EXECUTIVE OFFICER | Sell | 18,074 | $6.94 | $125.5K |
| Jun 12, 2026 | ADTX | Aditxt, Inc. | HRT FINANCIAL LP | 10 percent owner | Sell | 2,833,463 | $0.01 | $39.7K |
| Jun 12, 2026 | ISRG | Intuitive Surgical, Inc. | Brosius Mark | officer: EVP & Chief Mfg and Supply Cha | Sell | 48 | $413.19 | $19.8K |
| Jun 12, 2026 | SPRY | ARS Pharmaceuticals, Inc. | Karas Eric | officer: Chief Commercial Officer | Sell | 25,000 | $10.00 | $250.0K |
| Jun 12, 2026 | HTFL | Heartflow, Inc. Common Stock | Farquhar John C.M. | director, officer: Chief Executive Officer | Sell | 22,562 | $28.50 | $643.0K |
| Jun 12, 2026 | SNDX | Syndax Pharmaceuticals, Inc. | Botwood Nicholas A.J. | officer: Head of R&D, CMO | Sell | 65,515 | $18.07 | $1.18M |
| Jun 12, 2026 | NVNO | enVVeno Medical Corporation | Duhay Francis | director | Sell | 140 | $10.30 | $1.4K |
| Jun 12, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $549.23 | $5.22M |
| Jun 12, 2026 | LGND | Ligand Pharmaceuticals Incorporated | LAMATTINA JOHN L | director | Sell | 4,591 | $250.88 | $1.15M |
| Jun 12, 2026 | SMMT | Summit Therapeutics Inc. | DUGGAN ROBERT W | director, 10 percent owner, officer: Co-Chief Executive Officer | Buy | 3,810,000 | $13.12 | $49.99M |
| Jun 12, 2026 | FTRE | Fortrea Holdings Inc. | Morais Mark A. | officer: Chief Operating Officer | Sell | 4,674 | $16.82 | $78.6K |
| Jun 12, 2026 | STRR | Star Equity Holdings, Inc. | Eberwein Jeffrey E. | director, 10 percent owner, officer: Chief Executive Officer | Buy | 1,884 | $10.89 | $20.5K |
| Jun 12, 2026 | ELV | Elevance Health Inc. | Dixon Robert L JR | director | Sell | 151 | $401.77 | $60.7K |
| Jun 12, 2026 | ATEC | Alphatec Holdings, Inc. | MCGINNIS KAREN K | director | Sell | 6,050 | $8.01 | $48.5K |
| Jun 12, 2026 | UTHR | United Therapeutics Corporation | EDGEMOND JAMES | officer: CFO AND TREASURER | Sell | 10,000 | $549.29 | $5.49M |
| Jun 12, 2026 | LQDA | Liquidia Corporation | Bloch Stephen M | director | Sell | 388,223 | $68.61 | $26.63M |
| Jun 12, 2026 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | officer: Chief Medical Officer | Sell | 8,519 | $24.20 | $206.2K |
| Jun 12, 2026 | TMCI | Treace Medical Concepts, Inc. | Treace John T. | director, 10 percent owner, officer: Chief Executive Officer | Buy | 24,606 | $4.03 | $99.2K |
| Jun 12, 2026 | PCRX | Pacira BioSciences, Inc. | RIKER LAUREN | officer: Senior Vice President, Finance | Sell | 6,115 | $23.50 | $143.7K |
| Jun 12, 2026 | APGE | Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | Sell | 20,000 | $83.38 | $1.67M |
| Jun 12, 2026 | LGND | Ligand Pharmaceuticals Incorporated | Aryeh Jason | director | Sell | 5,000 | $250.00 | $1.25M |
| Jun 12, 2026 | QTRX | Quanterix Corporation | Meadows Benjamin | officer: Chief Commercial Officer | Buy | 3,500 | $2.77 | $9.7K |
| Jun 12, 2026 | JNJ | Johnson & Johnson | Wengel Kathryn E | officer: EVP, Chief TO and Risk Officer | Sell | 10,000 | $241.15 | $2.41M |
| Jun 12, 2026 | INDV | Indivior Pharmaceuticals Inc | Heidbreder Christian | officer: Chief Scientific Officer | Sell | 18,586 | $38.06 | $707.4K |
| Jun 12, 2026 | ALHC | Alignment Healthcare, Inc. | KONOWIECKI JOSEPH S | director, officer: EVP, Corporate Affairs | Sell | 25,000 | $21.00 | $525.0K |
| Jun 12, 2026 | CMND | Clearmind Medicine Inc. | HRT FINANCIAL LP | 10 percent owner | Buy | 2,159,052 | $0.15 | $330.3K |
| Jun 12, 2026 | SMMT | Summit Therapeutics Inc. | Zanganeh Mahkam | director, 10 percent owner, officer: Co-Chief Executive Officer | Buy | 3,810,000 | $13.12 | $49.99M |
| Jun 12, 2026 | ALHC | Alignment Healthcare, Inc. | KAO JOHN E | director, officer: Chief Executive Officer | Sell | 298,000 | $20.36 | $6.07M |
| Jun 12, 2026 | CMND | Clearmind Medicine Inc. | HRT FINANCIAL LP | 10 percent owner | Sell | 225,191 | $0.12 | $27.7K |
| Jun 12, 2026 | SPRY | ARS Pharmaceuticals, Inc. | Fitzpatrick Alexander A | officer: Chief Legal Officer | Sell | 3,355 | $10.00 | $33.5K |
| Jun 12, 2026 | WRBY | Warby Parker Inc. | Moon Youngme E | director | Sell | 10,000 | $26.53 | $265.3K |
| Jun 12, 2026 | RDGT | Ridgetech Inc. | HRT FINANCIAL LP | 10 percent owner | Buy | 19,373 | $1.61 | $31.2K |
| Jun 12, 2026 | COSM | Cosmos Health Inc. | Siokas Grigorios | director, 10 percent owner, officer: Chief Executive Officer | Buy | 919,894 | $0.22 | $205.0K |
| Jun 12, 2026 | ECOR | electroCore, Inc. | Goldberger Daniel S | other: Former Officer & Director | Sell | 80,000 | $6.80 | $544.0K |
| Jun 12, 2026 | GH | Guardant Health, Inc. | Kalia Kumud | officer: Chief Information Officer | Sell | 5,000 | $130.41 | $652.0K |
| Jun 12, 2026 | ORKA | Oruka Therapeutics, Inc. | Dambkowski Carl | director | Sell | 35,000 | $70.13 | $2.45M |
| Jun 11, 2026 | MCK | McKesson Corporation | TYLER BRIAN S. | director, officer: Chief Executive Officer | Sell | 4,929 | $763.00 | $3.76M |
| Jun 11, 2026 | SGHT | Sight Sciences, Inc. | Encrantz Staffan | director, 10 percent owner: | Buy | 14,100 | $4.88 | $68.8K |
| Jun 11, 2026 | GUTS | Fractyl Health, Inc. Common Stock | Sheffield Ian | director | Buy | 35,000 | $0.73 | $25.5K |
| Jun 11, 2026 | RDGT | Ridgetech Inc. | HRT FINANCIAL LP | 10 percent owner | Buy | 39,336 | $1.72 | $67.7K |
| Jun 11, 2026 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Jenkins John Kenneth | director | Sell | 4,800 | $7.91 | $38.0K |
| Jun 11, 2026 | NUVB | Nuvation Bio Inc. | Mashal Robert | director | Buy | 25,000 | $4.73 | $118.3K |
| Jun 11, 2026 | LYEL | Lyell Immunopharma, Inc. | Shook David | officer: Chief Medical Officer | Sell | 1,977 | $12.64 | $25.0K |
| Jun 11, 2026 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Kung Winston | director | Sell | 2,026 | $7.91 | $16.0K |
| Jun 11, 2026 | HOWL | Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | Sell | 678,226 | $0.37 | $253.6K |
| Jun 11, 2026 | AXSM | Axsome Therapeutics, Inc. | JEFFS ROGER | director | Sell | 572 | $247.65 | $141.7K |
| Jun 11, 2026 | GUTS | Fractyl Health, Inc. Common Stock | BRADLEY WILLIAM | director | Buy | 68,493 | $0.73 | $50.3K |
| Jun 11, 2026 | ARTV | Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Buy | 1,027,722 | $7.44 | $7.65M |
Showing 1–50 of 500
1 / 10
...